Skip to content

Retrospective analysis of the effects of piracetam on serum inflammatory factors and cerebral hemodynamics in patients with acute cerebral infarction: a clinical study

Retrospective analysis of the effects of piracetam on serum inflammatory factors and cerebral hemodynamics in patients with acute cerebral infarction: a clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125871
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute cerebral infarction

Interventions

Observation group:None
Control group:None

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of ACI and be confirmed by cranial imaging; 2.Age18~80; 3.Clinical data are complete;

Exclusion criteria

Exclusion criteria: 1. Patients with combined cerebral hemorrhage or hemorrhagic transformation; 2.Patients with severe cardiac, hepatic, and renal insufficiency; 3.Individuals with autoimmune diseases or those who have recently used immunosuppressants; 4.Those who have had infectious diseases in the past 2 weeks; 5.Those who are allergic to the study drug;

Design outcomes

Primary

MeasureTime frame
Inflammatory factor levels (CRP, IL-6); cerebral hemodynamic parameters [mean blood flow velocity (Vm), pulsatility index (PI)];

Secondary

MeasureTime frame
Therapeutic efficacy;Adverse reaction;

Countries

China

Contacts

Public ContactHongying Yu

Yuebei People’s Hospital

297115458@qq.com+86 751 6913465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026